Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
Karthaus M, Kretzschmar A, Kröning H, Biakhov M, Irwin D, Marschner N, Slabber C, Fountzilas G, Garin A, Abecasis NG, Baronius W, Steger GG, Südhoff T, Giorgetti C, Reichardt P. Karthaus M, et al. Among authors: irwin d. Ann Oncol. 2006 Feb;17(2):289-96. doi: 10.1093/annonc/mdj059. Epub 2005 Nov 29. Ann Oncol. 2006. PMID: 16317012 Free article. Clinical Trial.
Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER; COOL Investigators. Ponec D, et al. Among authors: irwin d. J Vasc Interv Radiol. 2001 Aug;12(8):951-5. doi: 10.1016/s1051-0443(07)61575-9. J Vasc Interv Radiol. 2001. PMID: 11487675 Clinical Trial.
Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy.
Wolk DA, Nelson PT, Apostolova L, Arfanakis K, Boyle PA, Carlsson CM, Corriveau-Lecavalier N, Dacks P, Dickerson BC, Domoto-Reilly K, Dugger BN, Edelmayer R, Fardo DW, Grothe MJ, Hohman TJ, Irwin DJ, Jicha GA, Jones DT, Kawas CH, Lee EB, Lincoln K, Maestre GE, Mormino EC, Onyike CU, Petersen RC, Rabinovici GD, Rademakers R, Raman R, Rascovsky K, Rissman RA, Rogalski E, Scheltens P, Sperling RA, Yang HS, Yu L, Zetterberg H, Schneider JA. Wolk DA, et al. Among authors: irwin dj. Alzheimers Dement. 2025 Jan 14:e14202. doi: 10.1002/alz.14202. Online ahead of print. Alzheimers Dement. 2025. PMID: 39807681
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia.
Vargas-Gonzalez JC, Dimal N, Cortez K, Heuer H, Forsberg LK, Appleby BS, Barmada S, Bozoki A, Clark D, Cobigo Y, Darby RR, Dickerson BC, Domoto-Reilly K, Galasko DR, Geschwind DH, Ghoshal N, Graff-Radford NR, Grant IM, Irwin D, Hsiung GR, Honig LS, Kantarci K, Léger GC, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Onyike CU, Pascual B, Pressman P, Ramos EM, Roberson ED, Rogalski E, Boeve BF, Boxer AL, Rosen HJ, Tartaglia MC; ALLFTD Consortium Investigators. Vargas-Gonzalez JC, et al. Among authors: irwin d. Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14448. Online ahead of print. Alzheimers Dement. 2024. PMID: 39713899
1,185 results